Showing 4971-4980 of 19420 results for "".
2,000 Years to End Female Genital Cutting
https://reachmd.com/programs/focus-on-global-medicine/2000-years-to-end-female-genital-cutting/3725/Molly Melching, founder of Tostan, an NGO organization based in Senegal, West Africa, that uses human rights education to empower communities around healthcare issues, joins host Dr. Maurice Pickard. They explore Tostan's successful education campaign on the health and human rights effects of femaleMDR and XDR-TB: Progress on Many Fronts
https://reachmd.com/programs/focus-on-global-medicine/mdr-and-xdr-tb-progress-on-many-fronts/3723/More than half a million people around the world are stricken with multi- or extensively drug-resistant tuberculosis every year, but only a fraction of these patients receive effective treatment for their disease. In a few TB hotspots in South America and Asia, we are seeing years of research investAre There Ways to Prevent Cancer?
https://reachmd.com/programs/clinicians-roundtable/are-there-ways-to-prevent-cancer/3695/How much do nutrition, environmental factors, exercise, and psychoneuroimmunology play role in helping your patients prevent and manage cancer? Dr. David Servan-Schreiber, clinical professor of psychiatry at the University of Pittsburgh School of Medicine and cofounder of the Center for IntegrativeDebulking Surgery and HIPC to Treat Ovarian Cancer
https://reachmd.com/programs/clinicians-roundtable/debulking-surgery-and-hipc-to-treat-ovarian-cancer/3690/According to the American Cancer Society, over 21,000 new cases of ovarian cancer are diagnosed each year with 15,000 more women dying annually. What are the recent developments in research to improve these odds? Dr. Robert Bristow, the director of the Kelly Gynecologic Oncology Service and the JohControlling MRSA Spread in Public Settings
https://reachmd.com/programs/focus-on-public-health-policy/controlling-mrsa-spread-in-public-settings/3667/Once thought to be a problem mainly in healthcare settings, methicillin-resistant Staphylococcus aureus (MRSA) infections are becoming increasingly common in the community. How can MRSA spread through the environment, and how can this spread be prevented? Jeffrey Hageman, an epidemiologist in the diResurrecting Antibodies from 1918 Flu Pandemic Survivors
https://reachmd.com/programs/clinicians-roundtable/resurrecting-antibodies-from-1918-flu-pandemic-survivors/3652/First published in 2005, the story of how we've come to understand the complete sequence of the 1918 pandemic influenza virus begins years ago, in a remote Alaskan village, and continues today in research across the country. What are we learning about a virus that has taken many decades to comprehenProprietary Data: Should Researchers Share?
https://reachmd.com/programs/focus-on-public-health-policy/proprietary-data-should-researchers-share/3651/Cancer researchers used to work in silos and would not share information until it was accepted for publication. Multi-disciplinary, intra-institution and inter-institution research teams are challenging the status quo. Is this a good thing, and what are the challenges? Join host Dr. Bruce Bloom as hCalculating the Value of a Physician Assistant
https://reachmd.com/programs/clinicians-roundtable/calculating-the-value-of-a-physician-assistant/3649/Ron Nelson, a physician assistant and president of Health Services Associates, Inc., discusses with host Lisa D'Andrea different models for calculating the value of a physician assistant to a medical practice. Mr. Nelson explains several compensation models that may be used for a physician assistanBack Pain Prevention
https://reachmd.com/programs/clinicians-roundtable/back-pain-prevention/3637/How might back pain be prevented? Dr. Stuart McGill, professor of spine biomechanics and chair of the Department of Kinesiology at the University of Waterloo, shares his research with host Dr. Leslie Lundt regarding the mechanisms of back injury. A greater understanding of these mechanisms can helpPsychoactive Drug Research: What's New with Hallucinogens?
https://reachmd.com/programs/clinicians-roundtable/psychoactive-drug-research-whats-new-with-hallucinogens/3634/It used to be common for researchers to study the potential medicinal uses for hallucinogenic drugs, including psilocybin, ecstasy, and LSD; however, the 60's left a blemish on legitimate research and it grinded to a halt. Host Dr. Leslie Lundt welcomes Dr. Matthew Johnson, a psychopharmacologist in